Seroquel Generics Suit Is AstraZeneca’s Bid To Control Diabetes Safety Data

FDA nearly always prevails in lawsuits that challenge generic approvals, but AstraZeneca’s argument is relatively fresh and could be bolstered by the agency’s decision to deny the firm’s citizen petition without comment.